Evidence map›Paper›PMID 42558097›Full record

ArticleJournal of medical extended reality2024

Perspective: The Promise of Virtual Reality as an Immersive Therapeutic.

Todd Maddox, Charisse Y Sparks, Liesl Oldstone, Michael Chibbaro, Josh Sackman, Emily Judge, Roselani Maddox, Robert Bonakdar, Beth D Darnall

Abstract read
In one paragraph

Article in Journal of medical extended reality, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Todd MaddoxAppliedVR, Inc., Van Nuys, California, USA.ORCID https://orcid.org/0000-0003-1265-4960
Charisse Y SparksInspire Medical Systems, Inc., Golden Valley, Minnesota, USA.
Liesl OldstoneAppliedVR, Inc., Van Nuys, California, USA.
Michael ChibbaroAppliedVR, Inc., Van Nuys, California, USA.
Josh SackmanAppliedVR, Inc., Van Nuys, California, USA.
Emily JudgeAppliedVR, Inc., Van Nuys, California, USA.
Roselani MaddoxAppliedVR, Inc., Van Nuys, California, USA.
Robert BonakdarScripps Center for Integrative Medicine, Scripps Clinic, La Jolla, California, USA.
Beth D DarnallDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this perspective, we discuss the promise of virtual reality (VR) as an immersive therapeutic (ITx) delivery device. We review the neurobiology of learning and show that VR broadly engages multiple learning systems in the brain in synchrony thus having the unique potential to increase the effectiveness and speed of therapeutic change. We examine one application of VR in the delivery of chronic pain management therapy. We discuss the strengths and weaknesses of current therapies such as pain education and cognitive behavior therapy and suggest that VR has the potential to deliver self-administered, accessible, low risk, in-home chronic pain therapy. We briefly review effectiveness data from an FDA-authorized 8-week self-administered behavioral skills VR program for chronic low-back pain called RelieVRx

Indexed as

chronic paincognitive behavior therapyimmersive therapeuticneurosciencevirtual reality

Identifiers

PMID42558097
PMCPMC13387222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.